These results suggest that CXCR3 signaling may mediate IL-8 expression in RGP cells, independent of constitutive BRAF signaling, and that CXCR3 may be a driver in melanoma progression in BRAFWT melanoma patients. The gene discussed is BRAF; the disease is melanoma.